Characterization and prognostic impact of ischemic etiology in heart failure with reduced left ventricular ejection fraction.

Back

ESC Professional Premium Access

Characterization and prognostic impact of ischemic etiology in heart failure with reduced left ventricular ejection fraction.

Session: Heart failure outcomes: effects of phenotypes and comorbidities

Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)

Speaker: Mr J. Perea Armijo (Cordoba, ES)

Event: ESC Congress 2023

Congress Presentation

About the speaker

Mr Jorge Perea Armijo

University Hospital Queen Sofia, Cordoba (Spain)

0 follower

6 more presentations in this session

Outcomes in patients admitted with diabetic ketoacidosis and heart failure with preserved ejection fraction

Speaker: Unknown H. Alagbo (Coimbra, PT)

Heart failure with mildly reduced ejection fraction is not all alike: the importance of disease trajectory

Speaker: Doctor J. Ferreira (Setubal, PT)

Inter-atrial block and atrial fibrillation predict cardiac adverse events in heart failure with preserved ejection fraction

Speaker: Ms H. Lopez Martinez (Badalona, ES)

Worse long term prognosis in new onset HFpEF treated in HF clinics compared to HFrEF and HFmrEF patients; reflecting need for effective treatment in HFpEF. Results from the Stockholm PREFERS Study.

Speaker: Doctor M. Ekstrom (Stockholm, SE)

Epicardial adipose tissue is associated with an increased risk of mortality and hospitalizations in patients with heart failure with preserved ejection fraction

Speaker: Doctor M. Grubler (Wiener Neustadt, AT)

Access the full session

Heart failure outcomes: effects of phenotypes and comorbidities

Speakers: Mr J. Perea Armijo, Unknown H. Alagbo, Doctor J. Ferreira, Ms H. Lopez Martinez, Doctor M. Ekstrom...

Access

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

Characterization and prognostic impact of ischemic etiology in heart failure with reduced left ventricular ejection fraction.

About the speaker

Mr Jorge Perea Armijo

6 more presentations in this session

Outcomes in patients admitted with diabetic ketoacidosis and heart failure with preserved ejection fraction

Heart failure with mildly reduced ejection fraction is not all alike: the importance of disease trajectory

Inter-atrial block and atrial fibrillation predict cardiac adverse events in heart failure with preserved ejection fraction

Worse long term prognosis in new onset HFpEF treated in HF clinics compared to HFrEF and HFmrEF patients; reflecting need for effective treatment in HFpEF. Results from the Stockholm PREFERS Study.

Epicardial adipose tissue is associated with an increased risk of mortality and hospitalizations in patients with heart failure with preserved ejection fraction

Access the full session

Heart failure outcomes: effects of phenotypes and comorbidities

About the event

ESC Congress 2023

ESC 365 is supported by